As of November 6, 2026, Pliant Therapeutics, Inc. is a publicly traded company (Nasdaq: PLRX); its largest reported holder is ADAR1 Capital, with 8.9% on Schedule 13G of August 14, 2026. The largest insider holding is Bernard Coulie, the chief executive and president, with 914,918 shares (1.5% of shares outstanding), per Form 4 of January 22, 2026 (Schedule 13G, August 14, 2026).
Is this your company?
About to sign with, pay or invest in Pliant Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Pliant Therapeutics, Inc. a real, registered company?
- Pliant Therapeutics, Inc. files with the SEC under CIK 1746473 (its SEC filings).
- Its shares are listed under the ticker PLRX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in South San Francisco, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Pliant Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Robert Iannone (Form 8-K filed 2026-07-13). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names ADAR1 Capital (filed 2026-08-14).
Who are Pliant Therapeutics, Inc.'s owners and officers?
Pliant Therapeutics, Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-14 | Adar1 Capital Management, LLC | 8.9% |
| Schedule 13G/A, 2026-08-14 | Kenneth Griffin | 3.5% |
| Schedule 13G/A, 2026-02-17 | Woodline Partners LP | 3.3% |
| Schedule 13G/A, 2026-02-17 | Point72 Asset Management, L.P. | 0.1% |
| Schedule 13G, 2026-02-09 | Kenneth Griffin | 5% |
| Schedule 13G, 2026-01-30 | Kenneth Griffin | 4.9% |
| Schedule 13G, 2026-01-22 | Kenneth Griffin | 4.9% |
| Schedule 13G/A, 2026-01-08 | Morgan Stanley | 0.9% |
| Schedule 13G/A, 2025-11-14 | Deep Track Capital, LP | 0% |
| Schedule 13G, 2025-11-14 | Woodline Partners LP | 7.3% |
| Schedule 13G, 2025-09-04 | Point72 Asset Management, L.P. | 6.7% |
| Schedule 13G/A, 2025-08-14 | Deep Track Capital, LP | 6.43% |
Questions about who owns Pliant Therapeutics, Inc.
Who owns Pliant Therapeutics, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Pliant Therapeutics, Inc.: Adar1 Capital Management, LLC (8.9%, Schedule 13G, filed 2026-08-14).
When did Adar1 Capital Management, LLC buy into Pliant Therapeutics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Adar1 Capital Management, LLC on this page is the Schedule 13G, filed 2026-08-14, reporting 8.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Pliant Therapeutics, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Pliant Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pliant Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-13 | Robert Iannone | appointed | ||
| Form 8-K, 2026-04-17 | I. Pyott | Chief Executive Officer | departed | |
| Form 8-K, 2026-04-17 | Katharine Knobil | Chief Executive Officer | departed | |
| Form 8-K, 2026-04-17 | Suzanne Bruhn | Chief Executive Officer | departed |
Which insiders own Pliant Therapeutics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 914,918 shares (1.5% of shares outstanding), 505,601 held directly and 409,317 indirectly (Form 4, 2026-01-22).
- , the chief financial officer: 297,214 shares (0.48% of shares outstanding) (Form 4, 2026-01-22).
- , the chief business officer: 265,693 shares (0.43% of shares outstanding), 251,708 held directly and 13,985 indirectly (Form 4, 2025-01-27).
- , the chief medical officer: 240,224 shares (0.39% of shares outstanding) (Form 4, 2025-01-27).
- , the general counsel and corp. sec'y: 105,544 shares (0.17% of shares outstanding) (Form 4, 2025-01-27).
Shares outstanding: 61,921,897 as of 2026-08-07, from the company's latest SEC cover page.
How much has Pliant Therapeutics, Inc. raised?
No fundraising or offering filing from Pliant Therapeutics, Inc. is on file with us.
Keep reading
More on Pliant Therapeutics, Inc. and the records around it.
Pliant Therapeutics, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes Jul 2026
Companies that share a holder
- Woodline Partners LP also filed stake reports on 19 other companies: Biohaven Ltd. (Aug 2026), Black Rock Coffee Bar, Inc. (Aug 2026), CalciMedica, Inc. (Aug 2026)
- ADAR1 Capital Management, LLC also filed stake reports on 29 other companies: InMed Pharmaceuticals, Inc. (Oct 2026), Tenax Therapeutics, Inc. (Sep 2026), Adagio Medical Holdings, Inc. (Aug 2026)
- Citadel Advisors LLC also filed stake reports on 58 other companies: Quantinuum Inc. (Oct 2026), REALLOYS INC. (Oct 2026), STARFIGHTERS SPACE, INC. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/pliant-therapeutics